Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Orum Therapeutics (475830 KS)
Watchlist
10
Analysis
Health Care
•
South Korea
Orum Therapeutics, Inc. operates as a clinical stage biotech company. The Company develops cell-penetrating antibodies, biomedical therapy applications, and pharmaceuticals for cancer and immune diseases. Orum Therapeutics serves clients worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Enf Technology
•
11 Mar 2026 05:40
KOSDAQ150 Index Rebalance Preview: Soaring AUM and Increased Flow/Impact
There could be 14 constituent changes for the KOSDAQ150 in June. AUM linked to the index has soared over the last couple of months. The forecast...
Brian Freitas
Follow
578 Views
Share
bullish
•
Orum Therapeutics
•
06 Apr 2026 11:04
Primer: Orum Therapeutics (475830 KS) - Apr 2026
Orum Therapeutics is a clinical-stage biotechnology company at the forefront of developing a novel class of cancer therapeutics called...
αSK Primers
137 Views
Share
bullish
•
Hyundai Movex
•
30 Mar 2026 22:14
An Update on the KOSDAQ 150 Rebalance Candidates in June 2026
Update on KOSDAQ 150 rebalance candidates in June 2026, with 8 potential addition candidates showing significant outperformance.
Douglas Kim
Follow
620 Views
Share
bullish
•
Alteogen Inc
•
08 Jan 2026 05:30
Alteogen (196170 KS): Index Impact of KOSDAQ to KOSPI Transfer
Alteogen's shareholders have approved the KOSDAQ to KOSPI transfer. Given recent delays, the timeline could be long drawn out. KOSPI200 buying will...
Brian Freitas
Follow
665 Views
Share
bullish
•
SemiFive
•
22 Dec 2025 19:30
An Early Look at Potential Additions and Deletions to KOSDAQ150 in June 2026
In this insight, we provide an early look at the potential additions and deletions to KOSDAQ 150 rebalance in June 2026. Of the eight potential...
Douglas Kim
Follow
2.1k Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x